Search research articles
Contact Us
Filters
Showing results (51-60 of 430) with videos related to
Page
of 43
Sort By:
Cancer
|
June 26, 2015
Reply to Treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphoma
Jessica N Williams, Jean L Koff, Christopher R Flowers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2018
Reply to J.A. Talcott
Randy A Taplitz, Erin B Kennedy, Christopher R Flowers
Journal of Oncology Practice
|
January 11, 2019
Clinical Implications of Febrile Neutropenia Guidelines in the Cancer Patient Population
Catherine C Braga, Randy A Taplitz, Christopher R Flowers
Hematology. American Society of Hematology. Education Program
|
December 4, 2018
Sequencing of therapies in relapsed follicular lymphoma
Loretta J Nastoupil, Christopher R Flowers, John P Leonard
JAMA Oncology
|
March 12, 2016
Perspectives in Oncology Drug Pricing-Reply
Daniel A Goldstein, David H Howard, Christopher R Flowers
Community Oncology
|
April 2, 2013
Considerations in the initial management of follicular lymphoma
Loretta Nastoupil, Rajni Sinha, Auldyn Hirschey, et al.
Hematology. American Society of Hematology. Education Program
|
December 4, 2018
Where to start? Upfront therapy for follicular lymphoma in 2018
John P Leonard, Loretta J Nastoupil, Christopher R Flowers
Hematology. American Society of Hematology. Education Program
|
December 4, 2018
Novel immunotherapy approaches to follicular lymphoma
Christopher R Flowers, John P Leonard, Loretta J Nastoupil
Oncology (Williston Park, N.Y.)
|
November 7, 2014
Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies
Loretta J Nastoupil, Jean L Koff, Christopher R Flowers
Blood
|
April 3, 2020
Lenalidomide in follicular lymphoma
Christopher R Flowers, John P Leonard, Nathan H Fowler
Page
of 43
Search research articles
Search
Showing results (51-60 of 430) with videos related to
Sort By:
Page
of 43
Cancer
|
June 26, 2015
Reply to Treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphoma
Jessica N Williams, Jean L Koff, Christopher R Flowers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2018
Reply to J.A. Talcott
Randy A Taplitz, Erin B Kennedy, Christopher R Flowers
Journal of Oncology Practice
|
January 11, 2019
Clinical Implications of Febrile Neutropenia Guidelines in the Cancer Patient Population
Catherine C Braga, Randy A Taplitz, Christopher R Flowers
Hematology. American Society of Hematology. Education Program
|
December 4, 2018
Sequencing of therapies in relapsed follicular lymphoma
Loretta J Nastoupil, Christopher R Flowers, John P Leonard
JAMA Oncology
|
March 12, 2016
Perspectives in Oncology Drug Pricing-Reply
Daniel A Goldstein, David H Howard, Christopher R Flowers
Community Oncology
|
April 2, 2013
Considerations in the initial management of follicular lymphoma
Loretta Nastoupil, Rajni Sinha, Auldyn Hirschey, et al.
Hematology. American Society of Hematology. Education Program
|
December 4, 2018
Where to start? Upfront therapy for follicular lymphoma in 2018
John P Leonard, Loretta J Nastoupil, Christopher R Flowers
Hematology. American Society of Hematology. Education Program
|
December 4, 2018
Novel immunotherapy approaches to follicular lymphoma
Christopher R Flowers, John P Leonard, Loretta J Nastoupil
Oncology (Williston Park, N.Y.)
|
November 7, 2014
Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies
Loretta J Nastoupil, Jean L Koff, Christopher R Flowers
Blood
|
April 3, 2020
Lenalidomide in follicular lymphoma
Christopher R Flowers, John P Leonard, Nathan H Fowler
Page
of 43